Notes to editor
This press release accompanies both a presentation and an ESC press conference at ESC Congress 2025.
It does not necessarily reflect the opinion of the European Society of Cardiology.
ESC Press Office
Tel: +33 6 61 40 18 84
Email: press@escardio.org
Follow European Society of Cardiology News on LinkedIn
Funding: The trial was supported by a grant from the European Union’s Horizon 2020 research and innovation programme. This study was also partly funded by the IHU LIRYC (L’Institut de Rythmologie et Modélisation Cardiaque). Partial financial support was received from Boston Scientific for system and catheter-related expenses.
Disclosures: Professor Jaïs reports receiving research grant and lecture fees from Boston Scientific, Biosense Webster, Medtronic and Abbott.
References and notes:
1‘BEAT PAROX AF: A randomised comparison of PFA vs. RFA’ presented during HOT LINE 8 on 31 August 2025 at 17:45 to 17:55 in Madrid (Main Auditorium).
2Reddy VY, Gerstenfeld EP, Natale A, et al. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med. 2023;389:1660−1671.
3Reichlin T, Kueffer T, Badertscher P, et al. Pulsed field or cryoballoon ablation for paroxysmal atrial fibrillation. N Engl J Med. 2025;392:1497−1507.
About ESC Congress 2025
It is the world’s largest gathering of cardiovascular professionals, disseminating ground-breaking science both onsite in Madrid and online – from 29 August to 1 September 2025. Explore the scientific programme. More information is available from the ESC Press Office at press@escardio.org.
About the European Society of Cardiology
The ESC brings together healthcare professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.